But the results, published in Thursday's New England Journal of
Medicine, show that many people given the heart-shocking vest
declined to wear it.
Among those who kept it on, their odds of death were 74 percent
lower compared to patients who kept in off during the three-month
test.
"There seems to be an effect if you wear it, and the effect is
pretty large," chief author Dr. Jeffrey Olgin of the University of
California, San Francisco's Center for the Prevention of Sudden
Death told Reuters Health in a telephone interview.
"I think the data, when you look into the details, are not
completely negative," said Dr. Valentina Kutyifa, a professor of
medicine at the University of Rochester Medical Center in a phone
interview with Reuters Health. She said because of poor compliance
the test raised more questions than it answered.
If a high-risk patient was highly motivated, "we would still offer
the wearable cardioverter-defibrillator" despite the official
conclusion of the Olgin study, said Dr. Michael Field of the Medical
University of South Carolina and Richard Page of the University
Wisconsin School of Medicine and Public Health in a Journal
editorial.

Zoll Medical, which makes the vests and is owned by Tokyo-based
Asahi Kasei Corporation, paid for the study, conducted at sites in
the U.S., Poland, Germany and Hungary.
The vest leases for about $3,000 per month.
Doctors have been seeking a way to keep heart attack survivors from
dying after their heart attack has cut the pumping efficiency of the
heart down to 35 percent or less.
One solution is to implant an automated defibrillator into the
chest. But that surgery isn't done immediately because studies have
shown that immediate implantation doesn't prevent death. It's not
clear why. Thus, current guidelines say implantation should not
occur unless 40 days have passed since a heart attack or 90 days
since narrowed blood vessels in the heart have been reopened.
So the Olgin team undertook the VEST study to see if a removable
defibrillator vest worn day and night for three months would lower
the risk of sudden death during the immediate aftermath of a heart
attack.
Based on the pre-set rules of the study, it didn't.
Although the rate of death from a bad heart rhythm was 1.6 percent
with the cotton vest versus 2.4 percent among those who didn't get
one, the difference wasn't large enough to rule out a statistical
fluke.
[to top of second column] |

The same was true with the rates of death from any cause, which were
3.1 percent among the adults wearing a defibrillator and 4.9 percent
in the control group.
However, of the 48 people who died after being given the device,
only 12 were wearing them at the time of their death.
When the researchers calculated the odds of death based on how long
the vests were worn, they estimated that there were 5 deaths for
every 1,000 people who wore then for a full month versus 19 deaths
for people who didn't wear them. By that measure, the vests made a
big difference.
When the experiment started, 81 percent assigned to the vest group
wore them for at least a little while each day. After 90 days, only
41 percent were doing it.
Frequent false alarms, skin irritation, inappropriate shocks and
emotional distress can deter some patients from continuing to wear
the device, said Drs. Field and Page.
One problem with the vest: Each day there was a 1 in 10 chance that
a patient would experience a false alarm. Nearly 1 in 10 people with
the device were exposed to more than 100 false alarms during the
90-day trial.
An alarm didn't always result in a shock to the heart. Patients who
heard the alarm go off yet felt fine could push a button to prevent
a jolt.
Dr. Olgin said patients seemed to have all-or-nothing approach to
the vest.
"What seems to be happening is, if you can tolerate wearing it, you
wear it all day," he said. "Those who wore it, wore it close to 24
hours a day."
Dr. Kutyifa, who published a study of vest-wearers last month, said
some people may be bothered by its tight fit. In addition, the four
electrodes embedded in the vest, which have direct contact with the
skin, "end up creating rashes in some patients."

SOURCE: https://bit.ly/2MXLa9L The New England Journal of Medicine,
online September 26, 2018.
(In paragraph 3, changes "three-year test" to "three-month test.")
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |